E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Public ClinicalTrials.gov record NCT02858310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
Study identification
- NCT ID
- NCT02858310
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Cancer Institute (NCI)
- NIH
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- Acetaminophen Drug
- Aldesleukin Drug
- Atropine sulfate Drug
- Biopsy Procedure
- Chest CT and MRI or PET Diagnostic Test
- Codeine sulfate Drug
- Cyclophosphamide Drug
- Diphenhydramine HCL Drug
- Diphenoxylate HCL Drug
- Droperidol Drug
- E7 TCR cells Biological
- EKG Diagnostic Test
- Fludarabine Drug
- Granisetron Drug
- Hydroxyzine HCL Drug
- Indomethacin Drug
- Loperamide Drug
- Meperidine Drug
- Ondansetron Drug
- PFT Diagnostic Test
- Prochlorperazine Drug
Drug · Procedure · Diagnostic Test + 1 more
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2017
- Primary completion
- Jul 1, 2025
- Completion
- Jul 1, 2025
- Last update posted
- Mar 8, 2026
2017 – 2025
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02858310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02858310 live on ClinicalTrials.gov.